Subscribe Become an Author Sign Up Log In

Ichor Biologics

Company
Founded
2014
Status
Private
Geography
United States of America based

About

Ichor Biologics specializes in the development of therapeutic monoclonal antibodies to treat infectious diseases. Our company has developed a platform for characterizing and isolating pathogen-specific antibodies from convalescent patients. This platform allows us to preserve neutralizing and non-neutralizing antibody functions, thereby increasing the likelihood of in-vivo efficacy. Our initial disease targets include viral infections, such as Hantaviruses and HBV.

Business model
  • Software as a Service / AI as Service (SaaS, AIaaS)
Therapeutic focus
  • Immunology
  • Infectious Diseases
Product type
  • Biologics
Research focus
  • Biology research (Target identification/validation)
  • Lead Discovery